Literature DB >> 8332211

Transcriptional antitermination.

J Greenblatt1, J R Nodwell, S W Mason.   

Abstract

Antiterminator proteins control gene expression by recognizing control signals near the promoter and preventing transcriptional termination which would otherwise occur at sites that may be a long way downstream. The N protein of bacteriophage lambda recognizes a sequence in the nascent RNA, and modifies RNA polymerase by catalysing the formation of a stable ribonucleoprotein complex on its surface, whereas the lambda Q protein recognizes a sequence in the DNA. These mechanisms of antitermination in lambda provide models for analysing antitermination in viruses such as HIV-1 and in eukaryotic genes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8332211     DOI: 10.1038/364401a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  77 in total

1.  Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences.

Authors:  Cyril F Bourgeois; Young Kyeung Kim; Mark J Churcher; Michelle J West; Jonathan Karn
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

2.  Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes.

Authors:  Ran Taube; Xin Lin; Dan Irwin; Koh Fujinaga; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

3.  Putative intermediary stages for the molecular evolution from a ribozyme to a catalytic RNP.

Authors:  Yoshiya Ikawa; Kentaro Tsuda; Shigeyoshi Matsumura; Shota Atsumi; Tan Inoue
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

4.  RNA polymerase mutations that impair conversion to a termination-resistant complex by Q antiterminator proteins.

Authors:  Thomas J Santangelo; Rachel Anne Mooney; Robert Landick; Jeffrey W Roberts
Journal:  Genes Dev       Date:  2003-05-15       Impact factor: 11.361

5.  Structural mimicry in the phage phi21 N peptide-boxB RNA complex.

Authors:  Christopher D Cilley; James R Williamson
Journal:  RNA       Date:  2003-06       Impact factor: 4.942

6.  Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element.

Authors:  Koh Fujinaga; Dan Irwin; Yehong Huang; Ran Taube; Takeshi Kurosu; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

7.  Selection of RRE RNA binding peptides using a kanamycin antitermination assay.

Authors:  Hadas Peled-Zehavi; Satoru Horiya; Chandreyee Das; Kazuo Harada; Alan D Frankel
Journal:  RNA       Date:  2003-02       Impact factor: 4.942

8.  The RNA-protein complex: direct probing of the interfacial recognition dynamics and its correlation with biological functions.

Authors:  Tianbing Xia; Hans-Christian Becker; Chaozhi Wan; Adam Frankel; Richard W Roberts; Ahmed H Zewail
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 11.205

9.  Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation.

Authors:  Michael Weik; Jens Modrof; Hans-Dieter Klenk; Stephan Becker; Elke Mühlberger
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Interaction between human respiratory syncytial virus (RSV) M2-1 and P proteins is required for reconstitution of M2-1-dependent RSV minigenome activity.

Authors:  Stephen W Mason; Erika Aberg; Carol Lawetz; Rachel DeLong; Paul Whitehead; Michel Liuzzi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.